Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis.
Zabotti A, De Marco G, Gossec L, Baraliakos X, Aletaha D, Iagnocco A, Gisondi P, Balint PV, Bertheussen H, Boehncke WH, Damjanov NS, de Wit M, Errichetti E, Marzo-Ortega H, Protopopov M, Puig L, Queiro R, Ruscitti P, Savage L, Schett G, Siebert S, Stamm TA, Studenic P, Tinazzi I, Van den Bosch FE, van der Helm-van Mil A, Watad A, Smolen JS, McGonagle DG. Zabotti A, et al. Ann Rheum Dis. 2023 Sep;82(9):1162-1170. doi: 10.1136/ard-2023-224148. Epub 2023 Jun 9. Ann Rheum Dis. 2023. PMID: 37295926 Free article.
Association between depression and anxiety and inability to achieve remission in rheumatoid arthritis and psoriatic arthritis.
Snoeck Henkemans SVJ, Vis M, Koc GH, Luime JJ, Kok MR, Tchetverikov I, van der Kooij SM, Bijsterbosch J, van der Helm-van Mil AHM, de Jong PHP. Snoeck Henkemans SVJ, et al. Among authors: van der helm van mil ahm. Rheumatology (Oxford). 2024 Nov 6:keae621. doi: 10.1093/rheumatology/keae621. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39504461
Combining patient-reported outcome measures to screen for active disease in rheumatoid arthritis and psoriatic arthritis.
Looijen AEM, Snoeck Henkemans SVJ, van der Helm-van Mil AHM, Welsing PMJ, Koc GH, Luime JJ, Kok MR, Tchetverikov I, Korswagen LA, Baudoin P, Vis M, de Jong PHP. Looijen AEM, et al. Among authors: van der helm van mil ahm. RMD Open. 2024 Oct 18;10(4):e004687. doi: 10.1136/rmdopen-2024-004687. RMD Open. 2024. PMID: 39424407 Free PMC article.
Development of rheumatoid arthritis after methotrexate in anticitrullinated protein antibody-negative people with clinically suspect arthralgia at risk of rheumatoid arthritis: 4-year data from the TREAT EARLIER trial.
Dumoulin QA, Krijbolder DI, Visser K, Lard LR, van der Helm-van Mil AHM. Dumoulin QA, et al. Among authors: van der helm van mil ahm. Lancet Rheumatol. 2024 Sep 17:S2665-9913(24)00196-6. doi: 10.1016/S2665-9913(24)00196-6. Online ahead of print. Lancet Rheumatol. 2024. PMID: 39303731
Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial.
van Mulligen E, Bour SS, Goossens LMA, de Jong PHP, Rutten-van Mölken M, van der Helm-van Mil A. van Mulligen E, et al. Among authors: van der helm van mil a. Ann Rheum Dis. 2024 Sep 18:ard-2024-226286. doi: 10.1136/ard-2024-226286. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39299721
Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease.
Deane KD, Holers VM, Emery P, Mankia K, El-Gabalawy H, Sparks JA, Costenbader KH, Schett G, van der Helm-van Mil A, van Schaardenburg D, Thomas R, Cope AP. Deane KD, et al. Among authors: van der helm van mil a. Ann Rheum Dis. 2024 Sep 24:ard-2023-224211. doi: 10.1136/ard-2023-224211. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39242182 Free article. Review.
392 results